Insider Cluster (3 insiders) ·Filed Apr 21, 2026
Insider cluster: 3 insiders, $15.5M total
Actionable Insight ▲ Bullish
The significant insider buying suggests confidence in upcoming catalysts. Monitor for news on clinical trials or partnerships that may have prompted this accumulation.
Final — all horizons settled through T+60d ⚠ clustered
PRLD ▼ -10.30% at T+60d
LONG call ✗ call lost -10.30% · α vs SPY -14.42% · entry $4.27 → $3.83
T+1d
+22.48%
call +22.48% · α +21.46%
$5.23
settled 6mo ago
T+5d
+13.35%
call +13.35% · α +10.24%
$4.84
settled 6mo ago
T+20d
-7.96%
call -7.96% · α -14.01%
$3.93
settled 5mo ago
T+60d
-10.30%
call -10.30% · α -14.42%
$3.83
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Three major insiders (OrbiMed Advisors, Baker Bros. Advisors, and David P. Bonita) purchased a combined $15.51M of PRLD shares at $4.44, representing ~5.4% of market cap. This is a strong vote of confidence from sophisticated healthcare investors.
Key Financial Metrics
Direction
buying
Total Value
$15.5M
Insiders
3
Key Facts
- Three director/10% owners purchased $15.51M of PRLD shares at $4.44
- Purchases represent ~5.4% of market cap
- Buyers include OrbiMed Advisors, Baker Bros. Advisors, and David P. Bonita
Financial Impact
$15.51M of insider purchases at $4.44 per share, ~5.4% of market cap
stock pricemarket sentiment
Risk Factors
- Biotech drug development risk
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PRLD-1777410925822 |
13 reports for PRLD
63% Hit rate @ T+1 Went positive at some point 6 of 8 best @ T+5▲ +9.37%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 5w ago | Institutional Cluster | $4.85 $4.31 | ▼ −11.13% | ▼ −10.41% | $3.88 (−20.00%) |
Sep 10, 2026 6w ago | 8-K | $4.67 $4.59 | ▼ −1.71% | ▼ −2.57% | $3.88 (−16.92%) |
Sep 10, 2026 6w ago | Press Release | $4.67 $4.59 | ▼ −1.71% | ▼ −2.57% | $3.88 (−16.92%) |
Aug 11, 2026 11w ago | 8-K | $5.32 $5.73 | ▲ +7.71% | ▲ +7.46% | $3.88 (−27.07%) |
Aug 11, 2026 11w ago | Press Release | $5.32 $5.73 | ▲ +7.71% | ▲ +7.46% | $3.88 (−27.07%) |
May 12, 2026 24w ago | 8-K | $4.64 $4.66 | ▲ +0.43% | ▼ −0.14% | $3.88 (−16.38%) |
May 12, 2026 24w ago | Press Release | $4.64 $4.66 | ▲ +0.43% | ▼ −0.14% | $3.88 (−16.38%) |
Apr 28, 2026 26w ago | 3 | $4.27 $4.27 | · 0.00% | ▼ −1.02% | $3.88 (−9.13%) |
Apr 21, 2026 27w ago | Insider Cluster | $4.27 $5.23 | ▲ +22.48% | ▲ +21.46% | $3.88 (−9.13%) |
Apr 20, 2026 27w ago | 8-K | $4.51 $4.62 | ▲ +2.44% | ▲ +3.09% | $3.88 (−13.97%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Thu (11h 37m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers